![]() Ribon Therapeutics Ribon Therapeutics discovers and develops novel small molecule therapeutics for major unmet medical needs. | ![]() Zenith Epigenetics Zenith Epigenetics is a biotechnology company developing bromodomain (BET) inhibitors for the treatment of cancer and other disorders. | |||
Founding Date | Founding Date 2009 | Founding Date 2015 | Founding Date 2009 | Founding Date 2013 |
Type | Type Private | Type Private | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Évry, FR HQ | Locations Cambridge, US HQ | Locations Lund, SE HQ Lund, SE Lund, SE | Locations San Francisco, US HQ Calgary, CA |
Employees | Employees 7 | Employees 614% decrease | Employees 15 | Employees 118% decrease |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 65m | Total funding raised $ 934.5k | Total funding raised $ 16.6m |

Ribon Therapeutics discovers and develops novel small molecule therapeutics for major unmet medical needs.
View companyXintela is a biomedical company working in the fields of regenerative medicine and cancer.
View company
Zenith Epigenetics is a biotechnology company developing bromodomain (BET) inhibitors for the treatment of cancer and other disorders.
View company